Lectures and seminars MedTechLabs Seminar online April 29 at 16.00 - 17.00

29-04-2021 4:00 pm - 5:00 pm Add to iCal

The power of innovation - Valuation of research initiatives: top class results for MedTechLabs

The use of modern intelligence tools to boost innovation efficiency will change the way we interpret innovation. The entities with the best and earliest forecasting and evaluation tools of technological trends and evolution can most effectively optimize innovation investments and gain early lead in critical technology areas.

Lecturer: Måns Marklund, CEO Cascelotte
Online: April 29 at 16.00 - 17.00
Sign up 
A confirmation will be sent to you directly together with an on-line link to the seminar.

Mr. Marklund has more than 20 years of experience of intellectual property and innovation intelligence. He is the former director of the training and knowledge center at the Swedish Intellectual Property Office. As an expert in national and international patent systems he worked closely with the World Intellectual Property Organization in developing the international patent system (PCT). Mr. Marklund has solid experience in advanced training and services in innovation and intellectual property as well as in business creation of innovation data and analytics. He holds a Master of Science in Engineering Physics from KTH, Royal Institute of Technology. In 2020 he founded the company Cascelotte AB, specializing in AI supported analytics of innovation.

Research is simultaneously becoming more competitive and collaborative. Countries like US, China and Korea are advancing their positions by using intelligent tools to focus their strategies and efforts. A recent publication in the North Caroline Journal on Law & Technology summarizes some of the efforts in a “Counterstrategy for innovation warfare.” It includes using future oriented technology intelligence to identify possible technological futures. With this publication as a starting point Mr. Marklund will discuss the use of innovation analytics referring to results from some of Cascelotte’s recent reports:
- CRISPR/Cas9 development, astonishing research results but low measurable innovation output for Swedish companies and Swedish business initiatives.
- MedTechLabs, world class results comparable to, or exceeding, some of the very best research centers in the world, indicating that this initiative will contribute to prosperity and jobs in Sweden.
- Macroanalysis of Swedish innovation showing a downturn in relative patent value.


Lena Lewin Scientific coordinator